Experimental tumoricidal effects of monoclonal antibody against solid breast tumors.
AUTOR(ES)
Capone, P M
RESUMO
Two distinct monoclonal antibodies (mAbs) were effective in the therapy of breast carcinomas of human origin established and growing in nude mice. Passive administration of either of the antibodies produced very rapid (less than 1 week) and significant reduction of in vivo tumor volume. Each of the mAbs showed in vivo targeting of the tumors. Histological analysis of mAb-treated tumors revealed extensive cellular necrosis. Each of the antibodies in vitro was effective in complement-mediated cytolysis at a concentration less than 1 ng/ml. The tumoricidal responses show that this is a useful model for passive human immunotherapy using mAbs.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=390048Documentos Relacionados
- Antibody response of mice to chemically induced tumors.
- Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody.
- Selective changes in expression of HLA class I polymorphic determinants in human solid tumors.
- Brain tumors.
- Two L-asparaginases from E. coli and their action against tumors.
